Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fertilization in Vitro | 36 | 2024 | 1292 | 6.250 |
Why?
|
Endocrine Disruptors | 9 | 2024 | 264 | 3.720 |
Why?
|
Follicular Fluid | 7 | 2024 | 92 | 3.670 |
Why?
|
Phenols | 9 | 2024 | 517 | 3.550 |
Why?
|
Oocytes | 17 | 2020 | 1166 | 3.200 |
Why?
|
Granulosa Cells | 7 | 2019 | 115 | 3.080 |
Why?
|
Phthalic Acids | 6 | 2024 | 478 | 2.880 |
Why?
|
Benzhydryl Compounds | 7 | 2019 | 916 | 2.360 |
Why?
|
Oogenesis | 6 | 2019 | 124 | 1.940 |
Why?
|
Ovulation Induction | 17 | 2024 | 277 | 1.910 |
Why?
|
Environmental Pollutants | 6 | 2024 | 1277 | 1.800 |
Why?
|
MicroRNAs | 9 | 2023 | 3816 | 1.780 |
Why?
|
Embryo Implantation | 5 | 2021 | 270 | 1.560 |
Why?
|
Pregnancy Outcome | 14 | 2022 | 2922 | 1.510 |
Why?
|
Infertility, Female | 9 | 2014 | 760 | 1.300 |
Why?
|
Pregnancy Rate | 17 | 2024 | 648 | 1.230 |
Why?
|
Fertilization | 3 | 2019 | 199 | 1.220 |
Why?
|
Dibutyl Phthalate | 2 | 2017 | 29 | 1.150 |
Why?
|
Embryo Transfer | 10 | 2022 | 522 | 1.130 |
Why?
|
Maternal Exposure | 3 | 2018 | 1067 | 1.090 |
Why?
|
Infertility | 5 | 2022 | 654 | 1.080 |
Why?
|
Progesterone | 6 | 2024 | 742 | 1.080 |
Why?
|
Maternal Age | 5 | 2021 | 809 | 1.000 |
Why?
|
Uterine Neoplasms | 6 | 2021 | 1420 | 0.980 |
Why?
|
Embryo, Mammalian | 6 | 2018 | 1674 | 0.970 |
Why?
|
Ovarian Follicle | 4 | 2021 | 244 | 0.970 |
Why?
|
Leiomyoma | 4 | 2021 | 636 | 0.950 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2024 | 71 | 0.930 |
Why?
|
Pregnancy | 51 | 2024 | 29890 | 0.930 |
Why?
|
Twins | 3 | 2021 | 339 | 0.880 |
Why?
|
Semen | 2 | 2024 | 347 | 0.870 |
Why?
|
Oocyte Retrieval | 9 | 2020 | 160 | 0.850 |
Why?
|
Chorionic Gonadotropin | 7 | 2023 | 457 | 0.840 |
Why?
|
Antiphospholipid Syndrome | 1 | 2024 | 165 | 0.830 |
Why?
|
Fertility | 6 | 2020 | 771 | 0.790 |
Why?
|
Anti-Mullerian Hormone | 1 | 2024 | 407 | 0.760 |
Why?
|
Placenta | 3 | 2023 | 1709 | 0.740 |
Why?
|
Estradiol | 4 | 2024 | 1937 | 0.730 |
Why?
|
Live Birth | 4 | 2020 | 511 | 0.700 |
Why?
|
Ovarian Hyperstimulation Syndrome | 3 | 2017 | 47 | 0.690 |
Why?
|
Sperm Injections, Intracytoplasmic | 5 | 2017 | 156 | 0.660 |
Why?
|
Cumulus Cells | 2 | 2018 | 22 | 0.630 |
Why?
|
Luteinization | 1 | 2017 | 10 | 0.600 |
Why?
|
Diethylhexyl Phthalate | 1 | 2018 | 83 | 0.590 |
Why?
|
Surrogate Mothers | 1 | 2017 | 16 | 0.570 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2018 | 187 | 0.550 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2016 | 52 | 0.550 |
Why?
|
Carbonated Beverages | 1 | 2017 | 210 | 0.530 |
Why?
|
Reproduction | 1 | 2021 | 645 | 0.530 |
Why?
|
Abortion, Induced | 5 | 2008 | 462 | 0.520 |
Why?
|
Cryopreservation | 6 | 2022 | 728 | 0.500 |
Why?
|
Hysteroscopy | 2 | 2005 | 62 | 0.490 |
Why?
|
Embryonic Development | 3 | 2015 | 721 | 0.490 |
Why?
|
Cesarean Section | 3 | 2021 | 1398 | 0.480 |
Why?
|
Embryo Culture Techniques | 2 | 2012 | 84 | 0.480 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2020 | 518 | 0.470 |
Why?
|
Spermatogenesis | 1 | 2015 | 259 | 0.470 |
Why?
|
Quality Control | 2 | 2015 | 832 | 0.470 |
Why?
|
Female | 77 | 2024 | 392705 | 0.470 |
Why?
|
Plasticizers | 1 | 2014 | 52 | 0.470 |
Why?
|
Adult | 58 | 2024 | 221210 | 0.460 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2017 | 389 | 0.460 |
Why?
|
Fetal Blood | 1 | 2020 | 1347 | 0.450 |
Why?
|
Israel | 7 | 2021 | 726 | 0.440 |
Why?
|
Gonadotropin-Releasing Hormone | 7 | 2023 | 1148 | 0.430 |
Why?
|
Androgens | 1 | 2020 | 1286 | 0.430 |
Why?
|
Ultrasonic Therapy | 2 | 2012 | 215 | 0.420 |
Why?
|
Coffee | 1 | 2017 | 593 | 0.420 |
Why?
|
Caffeine | 1 | 2017 | 700 | 0.420 |
Why?
|
Gonadal Steroid Hormones | 1 | 2016 | 702 | 0.400 |
Why?
|
Abortion, Missed | 2 | 2008 | 12 | 0.380 |
Why?
|
Body Mass Index | 3 | 2019 | 12953 | 0.360 |
Why?
|
Pregnancy Complications | 4 | 2020 | 2947 | 0.360 |
Why?
|
Triplets | 1 | 2010 | 42 | 0.350 |
Why?
|
Misoprostol | 2 | 2008 | 93 | 0.350 |
Why?
|
Reproductive Techniques, Assisted | 4 | 2021 | 497 | 0.350 |
Why?
|
Humans | 82 | 2024 | 761596 | 0.340 |
Why?
|
Surgery, Computer-Assisted | 1 | 2017 | 1007 | 0.340 |
Why?
|
Fertility Agents, Female | 3 | 2014 | 101 | 0.340 |
Why?
|
Vagina | 2 | 2005 | 838 | 0.340 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1496 | 0.330 |
Why?
|
Obesity | 5 | 2015 | 12947 | 0.320 |
Why?
|
Abortifacient Agents, Nonsteroidal | 2 | 2008 | 64 | 0.310 |
Why?
|
Mifepristone | 3 | 2008 | 151 | 0.290 |
Why?
|
Cytoskeleton | 1 | 2012 | 1170 | 0.290 |
Why?
|
Retrospective Studies | 25 | 2024 | 80647 | 0.280 |
Why?
|
Endometrium | 2 | 2012 | 403 | 0.280 |
Why?
|
Pain, Intractable | 1 | 2007 | 132 | 0.270 |
Why?
|
Ovulation | 2 | 2018 | 181 | 0.260 |
Why?
|
Cells, Cultured | 6 | 2019 | 18966 | 0.260 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9420 | 0.250 |
Why?
|
Abortifacient Agents, Steroidal | 2 | 2008 | 22 | 0.240 |
Why?
|
Trophoblastic Tumor, Placental Site | 1 | 2005 | 20 | 0.240 |
Why?
|
Environmental Exposure | 4 | 2024 | 4485 | 0.240 |
Why?
|
Luteal Phase | 2 | 2015 | 138 | 0.230 |
Why?
|
Uterine Diseases | 1 | 2005 | 108 | 0.230 |
Why?
|
Overweight | 1 | 2015 | 2417 | 0.230 |
Why?
|
Gene Expression | 1 | 2016 | 7581 | 0.230 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2007 | 384 | 0.220 |
Why?
|
Gestational Age | 3 | 2020 | 3577 | 0.220 |
Why?
|
Inhibins | 1 | 2024 | 210 | 0.220 |
Why?
|
High-Intensity Focused Ultrasound Ablation | 2 | 2021 | 40 | 0.220 |
Why?
|
Polyps | 1 | 2005 | 200 | 0.210 |
Why?
|
Delivery, Obstetric | 1 | 2010 | 941 | 0.210 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10766 | 0.200 |
Why?
|
Abortion, Legal | 1 | 2003 | 114 | 0.200 |
Why?
|
Blastocyst | 2 | 2017 | 433 | 0.200 |
Why?
|
Culture Media | 2 | 2016 | 897 | 0.200 |
Why?
|
Vaginal Discharge | 1 | 2022 | 25 | 0.200 |
Why?
|
Fallopian Tube Diseases | 1 | 2022 | 60 | 0.190 |
Why?
|
Cohort Studies | 9 | 2024 | 41495 | 0.190 |
Why?
|
Obesity, Morbid | 1 | 2012 | 1277 | 0.190 |
Why?
|
Single Embryo Transfer | 1 | 2020 | 29 | 0.180 |
Why?
|
Twins, Dizygotic | 1 | 2020 | 236 | 0.170 |
Why?
|
Prospective Studies | 10 | 2023 | 54423 | 0.170 |
Why?
|
Fas-Associated Death Domain Protein | 1 | 2019 | 27 | 0.170 |
Why?
|
Treatment Outcome | 12 | 2024 | 64685 | 0.170 |
Why?
|
Oocyte Donation | 1 | 2019 | 52 | 0.160 |
Why?
|
Religion and Medicine | 1 | 2000 | 161 | 0.160 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2009 | 2020 | 0.160 |
Why?
|
Pilot Projects | 4 | 2020 | 8633 | 0.160 |
Why?
|
Dicarboxylic Acids | 1 | 2018 | 77 | 0.150 |
Why?
|
Pregnancy, High-Risk | 1 | 2018 | 122 | 0.150 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2020 | 550 | 0.150 |
Why?
|
Precancerous Conditions | 1 | 2005 | 980 | 0.150 |
Why?
|
Young Adult | 9 | 2019 | 59260 | 0.150 |
Why?
|
Cholesterol Side-Chain Cleavage Enzyme | 1 | 2017 | 28 | 0.140 |
Why?
|
Cosmetics | 1 | 2018 | 102 | 0.140 |
Why?
|
Infant, Newborn | 6 | 2021 | 26202 | 0.140 |
Why?
|
Habits | 1 | 2017 | 147 | 0.140 |
Why?
|
Fertility Agents | 1 | 2016 | 11 | 0.140 |
Why?
|
Sperm Motility | 1 | 2018 | 266 | 0.130 |
Why?
|
Aromatase | 1 | 2017 | 147 | 0.130 |
Why?
|
Logistic Models | 3 | 2020 | 13255 | 0.130 |
Why?
|
PPAR gamma | 1 | 2019 | 484 | 0.130 |
Why?
|
Reproductive Control Agents | 1 | 2015 | 6 | 0.130 |
Why?
|
Internet | 2 | 2021 | 3093 | 0.130 |
Why?
|
Ethics, Medical | 1 | 2000 | 783 | 0.120 |
Why?
|
Neurosecretory Systems | 1 | 2016 | 223 | 0.120 |
Why?
|
Congenital Abnormalities | 1 | 2020 | 709 | 0.120 |
Why?
|
Ectogenesis | 1 | 2014 | 8 | 0.120 |
Why?
|
RNA, Messenger | 4 | 2018 | 12794 | 0.120 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2015 | 168 | 0.120 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21019 | 0.120 |
Why?
|
Bariatric Surgery | 2 | 2014 | 992 | 0.120 |
Why?
|
Hazardous Substances | 1 | 2015 | 153 | 0.120 |
Why?
|
Luteinizing Hormone | 1 | 2017 | 820 | 0.120 |
Why?
|
Spermatozoa | 1 | 2018 | 630 | 0.110 |
Why?
|
Gonadotropins | 1 | 2014 | 241 | 0.110 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 26129 | 0.110 |
Why?
|
Progestins | 1 | 2015 | 301 | 0.110 |
Why?
|
Placenta Diseases | 1 | 2015 | 199 | 0.110 |
Why?
|
Microscopy, Polarization | 1 | 2012 | 89 | 0.100 |
Why?
|
Metabolic Networks and Pathways | 1 | 2016 | 789 | 0.100 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2007 | 4024 | 0.100 |
Why?
|
Time-Lapse Imaging | 1 | 2012 | 194 | 0.100 |
Why?
|
Meiosis | 1 | 2013 | 328 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2019 | 11904 | 0.090 |
Why?
|
Edetic Acid | 1 | 2012 | 276 | 0.090 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2019 | 1935 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3415 | 0.090 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1509 | 0.090 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2012 | 202 | 0.090 |
Why?
|
Environmental Monitoring | 1 | 2017 | 1460 | 0.090 |
Why?
|
Follicle Stimulating Hormone | 2 | 2010 | 726 | 0.090 |
Why?
|
Apoptosis | 2 | 2017 | 9490 | 0.090 |
Why?
|
Patient Education as Topic | 1 | 2021 | 2319 | 0.090 |
Why?
|
Hospitals, University | 1 | 2012 | 564 | 0.090 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2019 | 3612 | 0.090 |
Why?
|
Ovarian Diseases | 1 | 2011 | 137 | 0.090 |
Why?
|
Infant, Low Birth Weight | 1 | 2015 | 870 | 0.090 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2012 | 395 | 0.090 |
Why?
|
Chromosomes | 1 | 2013 | 578 | 0.090 |
Why?
|
Orchiopexy | 1 | 2009 | 20 | 0.090 |
Why?
|
Metabolic Diseases | 1 | 2016 | 683 | 0.090 |
Why?
|
Sperm Retrieval | 1 | 2009 | 23 | 0.090 |
Why?
|
Testosterone | 1 | 2020 | 2472 | 0.080 |
Why?
|
Ovary | 1 | 2014 | 959 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2007 | 9280 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3779 | 0.080 |
Why?
|
Cryptorchidism | 1 | 2009 | 151 | 0.080 |
Why?
|
Risk Assessment | 3 | 2021 | 23996 | 0.080 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2009 | 84 | 0.080 |
Why?
|
Ultrasonography | 3 | 2007 | 5971 | 0.080 |
Why?
|
Middle Aged | 10 | 2019 | 220921 | 0.080 |
Why?
|
Cell Communication | 1 | 2015 | 1657 | 0.080 |
Why?
|
Health Expenditures | 1 | 2021 | 2366 | 0.080 |
Why?
|
Fetal Macrosomia | 1 | 2009 | 141 | 0.080 |
Why?
|
Cell Cycle | 1 | 2016 | 2932 | 0.080 |
Why?
|
Cell Size | 1 | 2010 | 624 | 0.080 |
Why?
|
Child Development | 1 | 2020 | 2306 | 0.080 |
Why?
|
Phosphoproteins | 1 | 2017 | 2448 | 0.070 |
Why?
|
Hormone Antagonists | 3 | 2014 | 107 | 0.070 |
Why?
|
Treatment Failure | 3 | 2012 | 2643 | 0.070 |
Why?
|
Ibuprofen | 1 | 2008 | 229 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2017 | 2986 | 0.070 |
Why?
|
Quality of Life | 2 | 2018 | 13367 | 0.070 |
Why?
|
Testis | 1 | 2009 | 794 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3449 | 0.060 |
Why?
|
Male | 8 | 2024 | 360846 | 0.060 |
Why?
|
Cell Culture Techniques | 1 | 2013 | 1668 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3492 | 0.060 |
Why?
|
Amino Acids | 1 | 2012 | 1718 | 0.060 |
Why?
|
Pregnancy, Multiple | 1 | 2006 | 215 | 0.060 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2645 | 0.060 |
Why?
|
Professional Competence | 1 | 2008 | 431 | 0.060 |
Why?
|
Cervix Uteri | 1 | 2009 | 570 | 0.060 |
Why?
|
Risk Factors | 5 | 2021 | 74213 | 0.060 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2008 | 370 | 0.060 |
Why?
|
Time Factors | 4 | 2019 | 39969 | 0.060 |
Why?
|
Medical Staff, Hospital | 1 | 2008 | 601 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12059 | 0.060 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2016 | 2518 | 0.060 |
Why?
|
Acetaminophen | 1 | 2008 | 555 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2018 | 22176 | 0.060 |
Why?
|
Hospitals, Teaching | 1 | 2008 | 1156 | 0.050 |
Why?
|
Glucose | 2 | 2012 | 4347 | 0.050 |
Why?
|
Adolescent | 6 | 2020 | 88326 | 0.050 |
Why?
|
Birth Weight | 2 | 2021 | 2103 | 0.050 |
Why?
|
Torsion Abnormality | 1 | 2022 | 91 | 0.050 |
Why?
|
Societies, Medical | 1 | 2013 | 3905 | 0.050 |
Why?
|
Fallopian Tubes | 1 | 2022 | 178 | 0.050 |
Why?
|
Incidence | 1 | 2019 | 21355 | 0.050 |
Why?
|
Pre-Eclampsia | 2 | 2021 | 1231 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39106 | 0.050 |
Why?
|
Diabetes, Gestational | 2 | 2021 | 1248 | 0.050 |
Why?
|
Animals | 5 | 2016 | 168475 | 0.050 |
Why?
|
Premenopause | 1 | 2005 | 1039 | 0.040 |
Why?
|
Drug Therapy, Combination | 3 | 2016 | 6312 | 0.040 |
Why?
|
Patient Selection | 1 | 2012 | 4244 | 0.040 |
Why?
|
Birth Rate | 1 | 2021 | 168 | 0.040 |
Why?
|
Boston | 1 | 2012 | 9327 | 0.040 |
Why?
|
Tissue and Organ Harvesting | 1 | 2002 | 373 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2012 | 4062 | 0.040 |
Why?
|
Safety | 1 | 2003 | 1149 | 0.040 |
Why?
|
Metaphase | 1 | 2018 | 145 | 0.040 |
Why?
|
Vomiting | 1 | 2022 | 651 | 0.040 |
Why?
|
Genes, cdc | 1 | 2018 | 114 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2273 | 0.040 |
Why?
|
Parity | 1 | 2020 | 927 | 0.040 |
Why?
|
Freezing | 1 | 2018 | 311 | 0.030 |
Why?
|
Fetal Growth Retardation | 1 | 2020 | 580 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 36426 | 0.030 |
Why?
|
Luteolytic Agents | 1 | 2015 | 1 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2014 | 4853 | 0.030 |
Why?
|
Hot Temperature | 1 | 2002 | 1440 | 0.030 |
Why?
|
Connexin 43 | 1 | 2016 | 200 | 0.030 |
Why?
|
Cicatrix | 1 | 2021 | 798 | 0.030 |
Why?
|
Menotropins | 1 | 2014 | 41 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23447 | 0.030 |
Why?
|
Biopsy | 3 | 2012 | 6766 | 0.030 |
Why?
|
Italy | 1 | 2015 | 842 | 0.030 |
Why?
|
Pain | 1 | 2008 | 5073 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 8527 | 0.030 |
Why?
|
Information Dissemination | 1 | 2021 | 1126 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2015 | 803 | 0.020 |
Why?
|
Azoospermia | 1 | 2009 | 28 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14665 | 0.020 |
Why?
|
Cleavage Stage, Ovum | 1 | 2009 | 44 | 0.020 |
Why?
|
Postoperative Period | 1 | 2014 | 1814 | 0.020 |
Why?
|
Menstrual Cycle | 1 | 2012 | 539 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2012 | 1574 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 15266 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14608 | 0.020 |
Why?
|
Uterine Contraction | 1 | 2008 | 91 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2013 | 935 | 0.020 |
Why?
|
Laparoscopy | 1 | 2018 | 2036 | 0.020 |
Why?
|
Infertility, Male | 1 | 2009 | 395 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2009 | 1178 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2016 | 2639 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2009 | 376 | 0.020 |
Why?
|
Organ Size | 1 | 2009 | 2254 | 0.010 |
Why?
|
Age Factors | 2 | 2009 | 18399 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8656 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1265 | 0.010 |
Why?
|
Drug Combinations | 1 | 2006 | 2048 | 0.010 |
Why?
|
Ultrasonography, Prenatal | 1 | 2008 | 1755 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2005 | 58984 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8466 | 0.010 |
Why?
|
Child | 2 | 2020 | 80158 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5841 | 0.010 |
Why?
|
Aged | 2 | 2009 | 169310 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2009 | 11120 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2008 | 12341 | 0.010 |
Why?
|
Infant | 1 | 2009 | 36193 | 0.000 |
Why?
|
Child, Preschool | 1 | 2009 | 42232 | 0.000 |
Why?
|